Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis

Conclusions
Although not warranted for the general population, targeting high-risk smokers for serum pepsinogen screening may be a cost-effective strategy to reduce intestinal-type NCGA mortality.

Source: Gut - March 9, 2016 Category: Gastroenterology Authors: Yeh, J. M., Hur, C., Ward, Z., Schrag, D., Goldie, S. J. Tags: Pancreatic cancer Stomach Source Type: research